SOD1-targeting monoclonal antibodies (ProMIS Neurosciences)

N/A

Report date: 2025/06/11 10:36:12

Base Information

Drug NameSOD1-targeting monoclonal antibodies (ProMIS Neurosciences)

Drug Alias NameSOD1-targeting monoclonal antibody (ProMIS Neurosciences)SOD1-targeting monoclonal antibody (Amorfix/PREVENT)PMN-110PMN-130PMN-120 +[6]

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody

Mechanisms of ActionNeuroprotectantsSuperoxide dismutase modulators

TargetsSuperoxide dismutase

Therapy Area/IndicationsAmyotrophic Lateral SclerosisAlzheimer Disease

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryCanada

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesProMIS Neurosciences Inc

China Registration ClassN/A

Develop Information

Active CompaniesProMIS Neurosciences Inc

Inactive CompaniesPan-Provincial Vaccine Enterprise

Active IndicationsAmyotrophic Lateral Sclerosis

Inactive IndicationsAlzheimer Disease

Other Information

ATC CodeN/A